Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT00044356
Status:
COMPLETED
Last Update Posted:
2011-07-07
First Post:
2002-08-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Sponsor:
Vical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VCL-1005-208
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dmitri D. Kharkevitch, MD, PhD
Old Organization:
Vical Incorporated